Antonios Aliprantis, Head of Immunology Early Development Innovation and Strategy at Biogen, shared on LinkedIn:
“I am excited to share my new role at Biogen as Head of Immunology Early Development Innovation and Strategy after a wonderful 5 years at Flagship Pioneering and Pioneering Medicines.
I’ll be forever grateful for the last 5 years at Flagship Pioneering where I got to work alongside renowned company creators and seasoned R&D leaders to help transform breakthrough platform science into novel therapies for patients.
There are too many people to thank individually but Paul Biondi – thank you for being such a champion of my career at FSP.
Now I’m on to Biogen, a company with a deep legacy of addressing the needs of patients with the most difficult to treat conditions.
I’m thrilled to work with their team to leverage cutting edge science to drive a pipeline of medicines for patients struggling with challenging immunologic diseases.”
Other articles featuring Antonios Aliprantis on OncoDaily.